(Q38035173)

27 August 2017

Experimental models and therapeutic approaches for HBV. (English)

1 reference

27 August 2017

Maura Dandri

1

1 reference

27 August 2017

Marc Lütgehetmann

series ordinal

2

1 reference

27 August 2017

Jörg Petersen

series ordinal

3

1 reference

27 August 2017

17 August 2012

1 reference

Seminars in Immunopathology

27 August 2017

1 reference

27 August 2017

35

1 reference

27 August 2017

1

1 reference

27 August 2017

7-21

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-012-0335-7

27 August 2017

0 references

cites work

Hepatitis B viruses: reverse transcription a different way.

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus taxonomy and hepatitis B virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The natural history of chronic HBV infection and geographical differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus genotyping: current methods and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Prevention of hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatocellular carcinoma: the point of view of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus induced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The replication cycle of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus resistance to nucleos(t)ide analogues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Control of cccDNA function in hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus replication is regulated by the acetylation status of hepatitis B virus cccDNA-bound H3 and H4 histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Primary human hepatocytes--a valuable tool for investigation of apoptosis and hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Infection of a human hepatoma cell line by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Decreased infectivity of nucleoside analogs-resistant hepatitis B virus mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Characterization of a hepatitis B and hepatitis delta virus receptor binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

In vitro characterization of viral fitness of therapy-resistant hepatitis B variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatocyte polarization is essential for the productive entry of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The replication cycle of hepatitis B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Animal models for the study of HBV replication and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Asymmetric replication of duck hepatitis B virus DNA in liver cells: Free minus-strand DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatocyte turnover during resolution of a transient hepadnaviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Residual integrated viral DNA after hepadnavirus clearance by nucleoside analog therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Transmission of Type B Viral Hepatitis to Chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Cloned HBV DNA causes hepatitis in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Properties of recombinant hepatitis B vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Protective efficacy of a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Licensed recombinant hepatitis B vaccines protect chimpanzees against infection with the prototype surface gene mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Human hepatitis B vaccine from recombinant yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The half-life of hepatitis B virions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Immunology of hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Cytotoxic T cells and viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Noncytolytic control of viral infections by the innate and adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The size of the viral inoculum contributes to the outcome of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Chimp research under scrutiny.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Lab bred chimps despite ban.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Inhibitory effect of adefovir on viral DNA synthesis and covalently closed circular DNA formation in duck hepatitis B virus-infected hepatocytes in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

HBV and HDV replication in experimental models: effect of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Lamivudine therapy of WHV-infected woodchucks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Antiviral efficacy and pharmacokinetics of oral adefovir dipivoxil in chronically woodchuck hepatitis virus-infected woodchucks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Modulation of regulatory T-cell activity in combination with interleukin-12 increases hepatic tolerogenicity in woodchucks with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Isolation of a hepadnavirus from the woolly monkey, a New World primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Human hepatitis B virus and hepatocellular carcinoma I. Experimental infection of tree shrews with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Chronic infection with hepatitis B viruses and antiviral drug evaluation in uPA mice after liver repopulation with tupaia hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Immunobiology and pathogenesis of viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

MMPs are required for recruitment of antigen-nonspecific mononuclear cells into the liver by CTLs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Host-virus interactions during malaria infection in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Inhibition of hepatitis B virus in mice by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Differential dynamics of the peripheral and intrahepatic cytotoxic T lymphocyte response to hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus core antigen determines viral persistence in a C57BL/6 mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Complete reconstitution of mouse liver with xenogeneic hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Liver repopulation with xenogenic hepatocytes in B and T cell-deficient mice leads to chronic hepadnavirus infection and clonal growth of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis C virus replication in mice with chimeric human livers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The human liver-uPA-SCID mouse: a model for the evaluation of antiviral compounds against HBV and HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Chimeric mouse model of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Factors determining successful engraftment of hepatocytes and susceptibility to hepatitis B and C virus infection in uPA-SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Hepatitis B virus limits response of human hepatocytes to interferon-α in chimeric mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Near completely humanized liver in mice shows human-type metabolic responses to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Characteristics of hepatitis B virus genotype G coinfected with genotype H in chimeric mice carrying human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

HBx protein is indispensable for development of viraemia in human hepatocyte chimeric mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Emergence of a novel lamivudine-resistant hepatitis B virus variant with a substitution outside the YMDD motif.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-012-0335-7

The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks.

21 January 2018

1 reference

12 December 2020

The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes.

1 reference

12 December 2020

The tupaia model for the study of hepatitis B virus: direct infection and HBV genome transduction of primary tupaia hepatocytes.

1 reference

12 December 2020

Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection

1 reference

12 December 2020

Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication

1 reference

12 December 2020

In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice

1 reference

12 December 2020

Are cultured liver cells the right tool to investigate mechanisms of liver disease or hepatotoxicity?

1 reference

12 December 2020

A chronic carrierlike state is established in nude mice injected with cloned hepatitis B virus DNA

1 reference

12 December 2020

Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice.

1 reference

12 December 2020

In vitro experimental infection of primary human hepatocytes with hepatitis B virus

1 reference

12 December 2020

Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus

1 reference

12 December 2020

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B

1 reference

12 December 2020

In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.

1 reference

12 December 2020

Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results

1 reference

12 December 2020

Woodchuck hepatitis virus X protein is required for viral infection in vivo

1 reference

12 December 2020

Replacement of diseased mouse liver by hepatic cell transplantation

1 reference

12 December 2020

Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes

1 reference

12 December 2020

The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice

1 reference

12 December 2020

5' Triphosphorylated small interfering RNAs control replication of hepatitis B virus and induce an interferon response in human liver cells and mice

1 reference

12 December 2020

Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B

1 reference

12 December 2020

High-level hepatitis B virus replication in transgenic mice

1 reference

12 December 2020

Clevudine therapy with vaccine inhibits progression of chronic hepatitis and delays onset of hepatocellular carcinoma in chronic woodchuck hepatitis virus infection

1 reference

12 December 2020

Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

1 reference

12 December 2020

Human class I supertypes and CTL repertoires extend to chimpanzees.

1 reference

12 December 2020

A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients

1 reference

12 December 2020

Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication

1 reference

12 December 2020

Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo

1 reference

12 December 2020

Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide

1 reference

12 December 2020

10.1007/S00281-012-0335-7

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

0 references

1 reference